ArticleTranslational cancer research2023

Combining PARP inhibitors and platinum-based chemotherapy in metastatic triple negative and/or BRCA-associated breast cancer.

Consolacion Molto Valiente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.